Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 44 | 2024 | 5221 | 2.560 |
Why?
|
Lung Neoplasms | 66 | 2024 | 13102 | 2.390 |
Why?
|
Quinazolines | 27 | 2019 | 1356 | 2.240 |
Why?
|
Protein Kinase Inhibitors | 40 | 2023 | 5535 | 1.940 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 7 | 2019 | 130 | 1.800 |
Why?
|
Quinazolinones | 4 | 2021 | 221 | 1.370 |
Why?
|
Mutation | 48 | 2024 | 29786 | 1.060 |
Why?
|
Drug Resistance, Neoplasm | 21 | 2024 | 5172 | 1.030 |
Why?
|
Pyrazoles | 11 | 2024 | 1972 | 1.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 15 | 2024 | 1660 | 1.020 |
Why?
|
Leukemia, Myeloid, Acute | 7 | 2021 | 3523 | 0.960 |
Why?
|
Lactams | 2 | 2024 | 156 | 0.950 |
Why?
|
Antineoplastic Agents | 28 | 2022 | 13695 | 0.900 |
Why?
|
Aminopyridines | 2 | 2024 | 542 | 0.770 |
Why?
|
Mutagenesis, Insertional | 5 | 2021 | 655 | 0.760 |
Why?
|
Exons | 11 | 2023 | 2437 | 0.740 |
Why?
|
Benzene Derivatives | 1 | 2019 | 54 | 0.710 |
Why?
|
Adenocarcinoma | 17 | 2020 | 6364 | 0.700 |
Why?
|
Apoptosis | 19 | 2022 | 9727 | 0.690 |
Why?
|
Cell Line, Tumor | 38 | 2023 | 16689 | 0.680 |
Why?
|
Alternative Splicing | 3 | 2020 | 1117 | 0.670 |
Why?
|
Styrenes | 1 | 2018 | 23 | 0.660 |
Why?
|
Genes, erbB-1 | 4 | 2019 | 161 | 0.660 |
Why?
|
Molecular Targeted Therapy | 6 | 2018 | 2727 | 0.650 |
Why?
|
Alkynes | 1 | 2019 | 306 | 0.650 |
Why?
|
Cytidine Deaminase | 1 | 2020 | 252 | 0.630 |
Why?
|
Janus Kinase 2 | 4 | 2022 | 528 | 0.600 |
Why?
|
Proto-Oncogene Proteins | 10 | 2017 | 4554 | 0.530 |
Why?
|
CCAAT-Binding Factor | 1 | 2015 | 23 | 0.520 |
Why?
|
Pyridines | 8 | 2017 | 2825 | 0.470 |
Why?
|
HL-60 Cells | 4 | 2019 | 365 | 0.460 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2010 | 1157 | 0.450 |
Why?
|
Drug Screening Assays, Antitumor | 6 | 2019 | 730 | 0.440 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1581 | 0.420 |
Why?
|
Receptor, erbB-2 | 3 | 2022 | 2416 | 0.390 |
Why?
|
Cell Differentiation | 7 | 2021 | 11483 | 0.390 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.380 |
Why?
|
Benzopyrans | 1 | 2010 | 64 | 0.370 |
Why?
|
Chromans | 1 | 2010 | 122 | 0.370 |
Why?
|
Myeloproliferative Disorders | 3 | 2022 | 606 | 0.360 |
Why?
|
Transcription Factors | 5 | 2023 | 12208 | 0.360 |
Why?
|
Nitrophenols | 1 | 2010 | 172 | 0.350 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2010 | 131 | 0.350 |
Why?
|
Sesquiterpenes | 1 | 2010 | 177 | 0.350 |
Why?
|
beta Catenin | 1 | 2014 | 1059 | 0.340 |
Why?
|
Transcriptional Activation | 5 | 2021 | 1783 | 0.330 |
Why?
|
Erythroid Cells | 1 | 2010 | 238 | 0.320 |
Why?
|
Biomimetic Materials | 1 | 2010 | 179 | 0.320 |
Why?
|
Sequence Deletion | 2 | 2013 | 1526 | 0.300 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2022 | 3557 | 0.300 |
Why?
|
Sulfonamides | 2 | 2022 | 1938 | 0.290 |
Why?
|
Structure-Activity Relationship | 6 | 2019 | 3129 | 0.290 |
Why?
|
Lung | 5 | 2024 | 9856 | 0.270 |
Why?
|
DNA | 1 | 2020 | 7301 | 0.270 |
Why?
|
Biphenyl Compounds | 1 | 2010 | 913 | 0.260 |
Why?
|
Taxoids | 1 | 2009 | 666 | 0.260 |
Why?
|
Humans | 93 | 2024 | 744343 | 0.250 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2020 | 890 | 0.250 |
Why?
|
Cyclins | 1 | 2006 | 603 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2022 | 1434 | 0.240 |
Why?
|
Protein-Tyrosine Kinases | 7 | 2019 | 2455 | 0.240 |
Why?
|
Molecular Structure | 4 | 2021 | 1899 | 0.230 |
Why?
|
Acrylamides | 3 | 2019 | 255 | 0.230 |
Why?
|
Mice | 27 | 2024 | 81183 | 0.230 |
Why?
|
Pyrogallol | 1 | 2022 | 8 | 0.220 |
Why?
|
Leukemia, Neutrophilic, Chronic | 1 | 2002 | 12 | 0.220 |
Why?
|
Computer Simulation | 1 | 2016 | 6196 | 0.210 |
Why?
|
Lactams, Macrocyclic | 1 | 2024 | 320 | 0.210 |
Why?
|
Up-Regulation | 6 | 2021 | 4217 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2942 | 0.210 |
Why?
|
Granulocytes | 2 | 2018 | 548 | 0.210 |
Why?
|
Calpain | 1 | 2002 | 150 | 0.200 |
Why?
|
Fibroblast Growth Factor 9 | 1 | 2021 | 13 | 0.200 |
Why?
|
Membrane Proteins | 2 | 2010 | 7880 | 0.200 |
Why?
|
Cell Proliferation | 9 | 2023 | 10481 | 0.200 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2018 | 434 | 0.200 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 2021 | 286 | 0.200 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2023 | 713 | 0.200 |
Why?
|
Peroxiredoxins | 1 | 2021 | 51 | 0.200 |
Why?
|
Animals | 33 | 2024 | 168757 | 0.190 |
Why?
|
Histone Acetyltransferases | 1 | 2023 | 336 | 0.190 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2021 | 318 | 0.190 |
Why?
|
Aniline Compounds | 3 | 2019 | 986 | 0.180 |
Why?
|
Peptide Library | 2 | 2012 | 349 | 0.180 |
Why?
|
Models, Biological | 2 | 2016 | 9583 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2022 | 2503 | 0.180 |
Why?
|
Indolizines | 1 | 2019 | 37 | 0.180 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2021 | 345 | 0.170 |
Why?
|
Gene Rearrangement | 4 | 2020 | 1179 | 0.170 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9438 | 0.170 |
Why?
|
Blotting, Western | 6 | 2015 | 5179 | 0.170 |
Why?
|
Gene Deletion | 1 | 2007 | 2751 | 0.170 |
Why?
|
Genes, Neoplasm | 1 | 2020 | 376 | 0.160 |
Why?
|
Signal Transduction | 6 | 2023 | 23403 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2015 | 578 | 0.160 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 809 | 0.160 |
Why?
|
Cytoskeletal Proteins | 1 | 2024 | 1364 | 0.160 |
Why?
|
Leukopoiesis | 1 | 2018 | 56 | 0.160 |
Why?
|
Epithelial Cells | 1 | 2010 | 3690 | 0.160 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2019 | 10943 | 0.160 |
Why?
|
Myeloid Cells | 3 | 2021 | 810 | 0.160 |
Why?
|
Enzyme Inhibitors | 3 | 2021 | 3798 | 0.150 |
Why?
|
NAD | 1 | 2021 | 593 | 0.150 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2021 | 651 | 0.150 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 215 | 0.150 |
Why?
|
Salicylamides | 1 | 2016 | 33 | 0.150 |
Why?
|
Base Sequence | 5 | 2017 | 12797 | 0.150 |
Why?
|
Trans-Activators | 3 | 2017 | 2924 | 0.150 |
Why?
|
Embolism, Air | 1 | 2017 | 111 | 0.140 |
Why?
|
4-Butyrolactone | 1 | 2016 | 63 | 0.140 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 1475 | 0.140 |
Why?
|
Carbazoles | 1 | 2018 | 226 | 0.140 |
Why?
|
Piperidines | 3 | 2018 | 1602 | 0.140 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2021 | 388 | 0.140 |
Why?
|
Microtubule-Associated Proteins | 1 | 2021 | 1086 | 0.140 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4253 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2024 | 4034 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2016 | 8428 | 0.130 |
Why?
|
Gene Amplification | 3 | 2015 | 1063 | 0.130 |
Why?
|
Phosphorylation | 9 | 2020 | 8436 | 0.130 |
Why?
|
Tumor Burden | 3 | 2021 | 1915 | 0.130 |
Why?
|
Brain Neoplasms | 3 | 2022 | 8863 | 0.130 |
Why?
|
Mixed Function Oxygenases | 1 | 2016 | 272 | 0.130 |
Why?
|
RNA Splicing | 1 | 2020 | 907 | 0.130 |
Why?
|
Leukemia | 1 | 2022 | 1511 | 0.120 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2016 | 358 | 0.120 |
Why?
|
Fatal Outcome | 3 | 2017 | 1850 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 474 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2016 | 4420 | 0.120 |
Why?
|
Genes, Reporter | 2 | 2015 | 1547 | 0.120 |
Why?
|
Drug Design | 2 | 2016 | 1076 | 0.110 |
Why?
|
Autopsy | 1 | 2017 | 1020 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2938 | 0.110 |
Why?
|
Drug Synergism | 2 | 2016 | 1792 | 0.110 |
Why?
|
Luciferases | 1 | 2015 | 733 | 0.110 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18029 | 0.110 |
Why?
|
Transcription, Genetic | 5 | 2021 | 7722 | 0.110 |
Why?
|
Doxycycline | 1 | 2014 | 326 | 0.110 |
Why?
|
Cell Survival | 3 | 2021 | 5882 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2020 | 2109 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 720 | 0.110 |
Why?
|
Protein Stability | 1 | 2014 | 557 | 0.110 |
Why?
|
Cell Line | 5 | 2021 | 15997 | 0.110 |
Why?
|
ATP Citrate (pro-S)-Lyase | 1 | 2012 | 26 | 0.110 |
Why?
|
Neutrophils | 2 | 2002 | 3719 | 0.110 |
Why?
|
Tretinoin | 1 | 2015 | 517 | 0.110 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2012 | 67 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11524 | 0.100 |
Why?
|
Hematopoiesis | 2 | 2018 | 2072 | 0.100 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5867 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2014 | 2564 | 0.100 |
Why?
|
Tumor Microenvironment | 3 | 2022 | 3586 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2018 | 1375 | 0.100 |
Why?
|
DNA Methylation | 3 | 2021 | 4286 | 0.100 |
Why?
|
Phosphatidic Acids | 1 | 2010 | 49 | 0.100 |
Why?
|
K562 Cells | 2 | 2010 | 634 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1142 | 0.100 |
Why?
|
E2F Transcription Factors | 1 | 2011 | 277 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2948 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2505 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2020 | 1715 | 0.090 |
Why?
|
Dual Specificity Phosphatase 6 | 1 | 2010 | 13 | 0.090 |
Why?
|
Tumor Cells, Cultured | 2 | 2016 | 6314 | 0.090 |
Why?
|
Pyrimidines | 2 | 2021 | 2942 | 0.090 |
Why?
|
MAP Kinase Signaling System | 3 | 2016 | 1526 | 0.090 |
Why?
|
Cell Growth Processes | 2 | 2013 | 399 | 0.090 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2010 | 67 | 0.090 |
Why?
|
Mice, Transgenic | 4 | 2023 | 9734 | 0.090 |
Why?
|
Alkanesulfonic Acids | 1 | 2012 | 180 | 0.090 |
Why?
|
Etoposide | 1 | 2011 | 641 | 0.090 |
Why?
|
Glioblastoma | 2 | 2022 | 3481 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11366 | 0.090 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2734 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 944 | 0.090 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11031 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3703 | 0.080 |
Why?
|
Female | 27 | 2021 | 380194 | 0.080 |
Why?
|
Mutant Proteins | 2 | 2010 | 500 | 0.080 |
Why?
|
Mitochondria | 2 | 2021 | 3520 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2020 | 19229 | 0.080 |
Why?
|
Polycythemia Vera | 1 | 2010 | 164 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3597 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 3760 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2012 | 5021 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2499 | 0.080 |
Why?
|
Glucose Transporter Type 4 | 1 | 2008 | 250 | 0.080 |
Why?
|
Aged | 15 | 2021 | 163280 | 0.080 |
Why?
|
Thoracic Wall | 1 | 2009 | 203 | 0.080 |
Why?
|
Oleanolic Acid | 1 | 2007 | 43 | 0.080 |
Why?
|
Mice, Nude | 3 | 2021 | 3689 | 0.070 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 675 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 625 | 0.070 |
Why?
|
Proteins | 1 | 2002 | 6103 | 0.070 |
Why?
|
Fluorocarbons | 1 | 2012 | 452 | 0.070 |
Why?
|
DNA Mutational Analysis | 2 | 2013 | 4186 | 0.070 |
Why?
|
Male | 20 | 2020 | 350118 | 0.070 |
Why?
|
Cyclin D | 1 | 2006 | 71 | 0.070 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2009 | 273 | 0.070 |
Why?
|
Survival Rate | 3 | 2017 | 12788 | 0.070 |
Why?
|
Down-Regulation | 2 | 2012 | 3002 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1420 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2016 | 3200 | 0.070 |
Why?
|
Middle Aged | 15 | 2019 | 213383 | 0.070 |
Why?
|
Pneumothorax | 1 | 2009 | 379 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2849 | 0.070 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2006 | 189 | 0.070 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2010 | 602 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 664 | 0.070 |
Why?
|
Oxygen | 1 | 2017 | 4189 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2018 | 57776 | 0.060 |
Why?
|
Caspases | 2 | 1999 | 928 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2014 | 4204 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2013 | 1758 | 0.060 |
Why?
|
Models, Structural | 1 | 2005 | 361 | 0.060 |
Why?
|
STAT5 Transcription Factor | 1 | 2005 | 259 | 0.060 |
Why?
|
Cycloheximide | 2 | 2002 | 347 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6544 | 0.060 |
Why?
|
Milk Proteins | 1 | 2005 | 169 | 0.060 |
Why?
|
Transfection | 3 | 2009 | 5892 | 0.060 |
Why?
|
Caspase 3 | 3 | 2002 | 758 | 0.060 |
Why?
|
Interleukin-3 | 1 | 2005 | 444 | 0.060 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 707 | 0.060 |
Why?
|
Genotype | 3 | 2015 | 12951 | 0.060 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2006 | 434 | 0.060 |
Why?
|
Alopecia | 1 | 2007 | 382 | 0.060 |
Why?
|
Flavonoids | 1 | 2006 | 443 | 0.060 |
Why?
|
Amino Acid Sequence | 4 | 2021 | 13815 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2006 | 671 | 0.060 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2006 | 266 | 0.060 |
Why?
|
Tyrphostins | 1 | 2022 | 67 | 0.060 |
Why?
|
Thymidine Phosphorylase | 1 | 2002 | 15 | 0.050 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2002 | 63 | 0.050 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2022 | 148 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2019 | 77449 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2005 | 769 | 0.050 |
Why?
|
Doxorubicin | 2 | 2019 | 2234 | 0.050 |
Why?
|
Proto-Oncogenes | 1 | 2022 | 321 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2015 | 14557 | 0.050 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2021 | 49 | 0.050 |
Why?
|
Polyenes | 1 | 2021 | 69 | 0.050 |
Why?
|
Prognosis | 4 | 2016 | 29063 | 0.050 |
Why?
|
Microscopy | 1 | 2006 | 903 | 0.050 |
Why?
|
Adipocytes | 1 | 2008 | 1184 | 0.050 |
Why?
|
Erythroid Precursor Cells | 1 | 2021 | 218 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2010 | 2107 | 0.050 |
Why?
|
Epoxy Compounds | 1 | 2021 | 136 | 0.050 |
Why?
|
Drug Interactions | 1 | 2005 | 1460 | 0.050 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 373 | 0.050 |
Why?
|
Cell Transdifferentiation | 1 | 2021 | 172 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39050 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2021 | 411 | 0.050 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2021 | 462 | 0.050 |
Why?
|
Ethylnitrosourea | 1 | 2019 | 51 | 0.040 |
Why?
|
Reoperation | 1 | 2009 | 4201 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2021 | 440 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19905 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6895 | 0.040 |
Why?
|
Purines | 1 | 2023 | 594 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1623 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 481 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 697 | 0.040 |
Why?
|
Piperazines | 1 | 2010 | 2488 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2019 | 139 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20129 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 98 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2375 | 0.040 |
Why?
|
Republic of Korea | 1 | 2020 | 539 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2012 | 3647 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2023 | 749 | 0.040 |
Why?
|
Mucin-1 | 1 | 2023 | 543 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3920 | 0.040 |
Why?
|
Forensic Pathology | 1 | 2017 | 27 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1998 | 190 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2010 | 3479 | 0.040 |
Why?
|
Cell Aggregation | 1 | 2017 | 244 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2017 | 2649 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3255 | 0.040 |
Why?
|
Amino Acids | 1 | 2023 | 1736 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2017 | 146 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2005 | 2012 | 0.040 |
Why?
|
Nitriles | 1 | 2021 | 956 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1878 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2019 | 413 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 297 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1213 | 0.030 |
Why?
|
Treatment Outcome | 7 | 2019 | 63114 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2716 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2017 | 224 | 0.030 |
Why?
|
Image Enhancement | 1 | 2006 | 2921 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2021 | 13033 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3282 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1998 | 563 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1266 | 0.030 |
Why?
|
Pyrroles | 1 | 2021 | 1146 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 9274 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2012 | 6538 | 0.030 |
Why?
|
Protein Conformation | 2 | 2013 | 4011 | 0.030 |
Why?
|
Structural Homology, Protein | 1 | 2013 | 91 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2017 | 1202 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7799 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1813 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2013 | 18111 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2011 | 12072 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4803 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2133 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3386 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2006 | 3327 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1839 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1856 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20822 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3128 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4042 | 0.030 |
Why?
|
Biopsy | 1 | 2005 | 6756 | 0.030 |
Why?
|
Oligopeptides | 1 | 1998 | 1189 | 0.030 |
Why?
|
Protein Binding | 2 | 2017 | 9386 | 0.030 |
Why?
|
Models, Molecular | 2 | 2013 | 5456 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 9959 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6386 | 0.030 |
Why?
|
CpG Islands | 1 | 2016 | 1172 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 1941 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 2002 | 1583 | 0.030 |
Why?
|
Activin Receptors, Type II | 1 | 2012 | 127 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1903 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2015 | 1801 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2014 | 905 | 0.020 |
Why?
|
Genomic Instability | 1 | 2015 | 695 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2012 | 274 | 0.020 |
Why?
|
Phosphodiesterase I | 1 | 2010 | 7 | 0.020 |
Why?
|
Disease Progression | 1 | 2008 | 13284 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 1999 | 2077 | 0.020 |
Why?
|
Technology Transfer | 1 | 2011 | 44 | 0.020 |
Why?
|
Enzyme Activation | 3 | 2006 | 3701 | 0.020 |
Why?
|
Biotinylation | 1 | 2011 | 179 | 0.020 |
Why?
|
Adult | 8 | 2018 | 214055 | 0.020 |
Why?
|
Lysophospholipase | 1 | 2010 | 63 | 0.020 |
Why?
|
Prospective Studies | 4 | 2020 | 53288 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2440 | 0.020 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2010 | 76 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2013 | 767 | 0.020 |
Why?
|
Genomics | 2 | 2018 | 5720 | 0.020 |
Why?
|
Oncogenes | 1 | 2016 | 1265 | 0.020 |
Why?
|
Pyrophosphatases | 1 | 2010 | 137 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2916 | 0.020 |
Why?
|
Bacteriophage T7 | 1 | 2011 | 174 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 624 | 0.020 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2010 | 197 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1538 | 0.020 |
Why?
|
Cricetulus | 1 | 2011 | 816 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2216 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1726 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2013 | 2011 | 0.020 |
Why?
|
CHO Cells | 1 | 2011 | 1406 | 0.020 |
Why?
|
Caspase 9 | 2 | 1999 | 188 | 0.020 |
Why?
|
Caspase 8 | 2 | 1999 | 195 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15519 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9648 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 198 | 0.020 |
Why?
|
Genes, abl | 1 | 2007 | 72 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2009 | 677 | 0.020 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2007 | 143 | 0.020 |
Why?
|
Cricetinae | 1 | 2011 | 2472 | 0.020 |
Why?
|
Gene Dosage | 1 | 2012 | 1252 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1655 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 479 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2010 | 561 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2012 | 6622 | 0.020 |
Why?
|
Myeloid Progenitor Cells | 1 | 2007 | 111 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 686 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 648 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2011 | 841 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2007 | 107 | 0.020 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2006 | 47 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2005 | 9239 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2256 | 0.020 |
Why?
|
Genes, ras | 1 | 2009 | 690 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 1572 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2007 | 190 | 0.020 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2006 | 91 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3617 | 0.020 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2007 | 265 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13881 | 0.020 |
Why?
|
Retroviridae | 1 | 2008 | 914 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2006 | 293 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2007 | 629 | 0.020 |
Why?
|
Serine | 1 | 2008 | 826 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2007 | 538 | 0.020 |
Why?
|
Cohort Studies | 1 | 2007 | 40561 | 0.010 |
Why?
|
Cell Cycle | 1 | 2012 | 2967 | 0.010 |
Why?
|
Biological Transport | 1 | 2008 | 2118 | 0.010 |
Why?
|
Plasmids | 1 | 2008 | 2307 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3047 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6234 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2006 | 2085 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5655 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4751 | 0.010 |
Why?
|
Protein Kinases | 1 | 2008 | 1640 | 0.010 |
Why?
|
Quinolines | 1 | 2006 | 732 | 0.010 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 689 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 21827 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3505 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 1114 | 0.010 |
Why?
|
Smoking | 1 | 2017 | 8987 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2007 | 2126 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8642 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3521 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4933 | 0.010 |
Why?
|
Affinity Labels | 1 | 1999 | 109 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3846 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4409 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1999 | 192 | 0.010 |
Why?
|
Medical Oncology | 1 | 2010 | 2265 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3479 | 0.010 |
Why?
|
Caspase 6 | 1 | 1998 | 15 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2002 | 1799 | 0.010 |
Why?
|
Caspase 7 | 1 | 1998 | 56 | 0.010 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 1998 | 45 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3508 | 0.010 |
Why?
|
Risk Assessment | 2 | 2011 | 23338 | 0.010 |
Why?
|
Software | 1 | 2012 | 4443 | 0.010 |
Why?
|
Superoxides | 1 | 1999 | 387 | 0.010 |
Why?
|
Recurrence | 1 | 2009 | 8340 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1998 | 242 | 0.010 |
Why?
|
Antigens, Nuclear | 1 | 1998 | 192 | 0.010 |
Why?
|
RNA Interference | 1 | 2006 | 2889 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3340 | 0.010 |
Why?
|
Jurkat Cells | 1 | 1998 | 743 | 0.010 |
Why?
|
Glucose | 1 | 2008 | 4397 | 0.010 |
Why?
|
Brain | 1 | 2022 | 26385 | 0.010 |
Why?
|
Immunoblotting | 1 | 1999 | 1682 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10397 | 0.010 |
Why?
|
Stem Cells | 1 | 2007 | 3567 | 0.010 |
Why?
|
Genome, Human | 1 | 2007 | 4420 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16365 | 0.010 |
Why?
|
Autoantigens | 1 | 1998 | 892 | 0.010 |
Why?
|
Neoplasms | 1 | 2021 | 21683 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18370 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14722 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17446 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10252 | 0.010 |
Why?
|
Time Factors | 1 | 2009 | 40075 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1998 | 5974 | 0.000 |
Why?
|
Cell Cycle Proteins | 1 | 1998 | 3462 | 0.000 |
Why?
|
Young Adult | 1 | 2009 | 56430 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 1998 | 5853 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 85781 | 0.000 |
Why?
|